DOW JONES27,960.80-1031.61 -3.56%
S&P 5003,225.89-111.86 -3.35%
NASDAQ9,221.28-355.31 -3.71%

JP Morgan Downgrades Vir Biotechnology to Neutral, Raises Price Target to $26

JP Morgan analyst Anupam Rama downgrades Vir Biotechnology (NASDAQ:VIR) from Overweight to Neutral and raises the price target from $25 to $26.

Benzinga · 02/04/2020 09:58

JP Morgan analyst Anupam Rama downgrades Vir Biotechnology (NASDAQ:VIR) from Overweight to Neutral and raises the price target from $25 to $26.